All the news Showing 10 of 156 articles from: United StatesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Coronavirus COVID-19 vaccine protection is ‘lower and slower’ in people with cirrhosis Keith Alcorn / 22 November 2021 People with cirrhosis of the liver may take longer to achieve protection from SARS-CoV-2 and severe COVID-19 after vaccination, according to large studies in the United States and Chile, presented earlier this month ... Hepatitis C elimination Hepatitis C treatment in US declined from 2015 to 2020 Liz Highleyman / 14 November 2021 From a height of more than 164,000 in 2015, the number of people treated with direct-acting antiviral (DAA) therapy for hepatitis C has steadily declined, reaching a low point during the COVID-19 pandemic, ... Treatment for people who use drugs Rapid hepatitis C treatment leads to high cure rate in young people who inject drugs Liz Highleyman / 12 October 2021 A simplified, same-day treatment model led to a higher cure rate compared with usual care for young people who inject drugs, according to research presented last week at the virtual IDWeek meeting. ... Coronavirus US CDC recommends third dose of Moderna or Pfizer COVID-19 vaccines for organ transplant recipients Keith Alcorn / 16 August 2021 People who have undergone a solid organ transplant and who received the Pfizer or Moderna COVID-19 vaccines should receive a third dose, the US Centers for Disease Control and Prevention (CDC) recommended ... NAFLD Food insecurity raises the risk of death in people with fatty liver disease Keith Alcorn / 28 June 2021 Food insecurity – limited or unreliable food supplies due to poverty – was associated with an increased risk of death in US adults with non-alcoholic fatty liver disease (NAFLD) or advanced fibrosis ... Liver transplants Liver transplant outcomes improve in people with HIV and hepatitis C Keith Alcorn / 21 June 2021 Survival after a liver transplant has improved significantly in people with HIV and hepatitis C co-infection since the introduction of direct-acting antiviral treatment for hepatitis C, US researchers report in the journal Transplantation ... Screening and testing policy COVID-19 reduced US hepatitis C testing, diagnosis and treatment Keith Alcorn / 21 May 2021 The COVID-19 pandemic severely reduced hepatitis C testing, diagnosis and treatment in the United States during 2020, a study by Quest Diagnostics and the US Centers for Disease Control and Prevention (CDC) ... Screening and testing policy Hepatitis C testing in gay and bisexual men with HIV below target, US study finds Keith Alcorn / 27 April 2021 Testing for hepatitis C among gay and bisexual men with HIV who are at higher risk of acquiring hepatitis C is falling short of recommendations, a study of a large US cohort ... Hepatitis C elimination Community-wide hepatitis C elimination campaign in Seattle increases number treated tenfold Keith Alcorn / 20 April 2021 A community-wide hepatitis C elimination campaign in Seattle, United States, tripled the number of people screened for hepatitis C and increased the number treated tenfold between 2014 and 2018, doctors and public health ... Sexual transmission Reinfection after hepatitis C cure predicted by sexually transmitted infections Keith Alcorn / 07 April 2021 Screening for sexually transmitted infections in people co-infected with HIV and hepatitis C during or shortly after completing direct-acting antiviral treatment to cure hepatitis C may predict which patients are at higher risk ... ← Prev12345...16Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive